Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Alebna PL, Han CY, Ambrosio M, Kong G, Cyrus JW, Harley K, et al
The Wegovy pills are expected to be available within weeks, company officials said
Supplements like GlyNAC are most effective when they are thoughtfully integrated into a comprehensive, holistic, and patient-centered management strategy
Genetic Engineering & Biotechnology News
Dagostino AN, Soule EH, Miller RH